TabletsClinical Overview
Chymotrypsin and Trypsin (1:6 ratio, 100K AU) Tablets is an oral systemic proteolytic enzyme preparation on the PMBI formulary. Following intestinal absorption, it breaks down peptide bonds in inflammatory fibrinous exudates, dissolves microthrombi in clogged capillary beds, restores microcirculation, accelerates resorption of inflammatory edema and hematomas, and facilitates antibiotic penetration into tissue. Indicated for post-traumatic and post-operative edema, soft tissue injuries, hematomas, tooth extraction inflammation, and pelvic inflammatory disease.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 1 tablet three times daily, on an empty stomach at least 30 to 45 minutes before meals with a full glass of water. Swallow whole; do not chew or crush.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Transient epigastric discomfort, nausea, loose stools, mild bloating. Rare/Severe: Allergic hypersensitivity reactions, bronchospasm, and urticaria.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Take on an empty stomach to avoid enzyme consumption by dietary proteins. Contraindicated in severe hemorrhagic diathesis, severe hepatic or renal dysfunction, and active peptic ulcer disease.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Trypsin 48mg + Bromelain 90mg + Rutoside Trihydrate 100mg Tablets
Trypsin 48mg + Bromelain 90mg + Rutoside Trihydrate 100mg Tablets is an established pharmaceutical agent in the Pain, Fever & Arthritis category on the PMBI National Formulary. Formulated to provide analgesic, antipyretic, anti-inflammatory, or chondroprotective relief according to verified pharmacopoeial standards.
Trypsin 48mg + Bromelain 90mg + Rutoside Trihydrate 100mg + Diclofenac Sodium 50mg Tablets
Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.